QUALITATIVE AND QUANTITATIVE COMPOSITION - …
BARACLUDE V6.0 1 DATA SHEET 1 PRODUCT NAME BARACLUDE 0.5 mg film-coated tablet BARACLUDE 1 mg film-coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.5 mg film-coated tablet contains 0.5 mg of entecavir. Each 1 mg film-coated tablet contains 1 …
Download QUALITATIVE AND QUANTITATIVE COMPOSITION - …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
South Carolina Department of Health and Human Services ...
southcarolina.fhsc.comGabapentin Savella ® Lyrica ® Tracleer® Morphine Sulfate ER* Morphine Sulfate SA Letairis ®* *Patients currently established on non-preferred therapy will be grandfathered.
Standard of procedures special authorization drugs list
www.healthsourceplus.com1 UPDATED March 3rd, 2014 Standard of procedures Special Authorization Drugs 1) General Section For all of the following drugs: Claims should be coordinate with the Provincial government program when available.
Hepatitis B Foundation Cause for a Cure
www.hepb.orgLiving With Hepatitis B What is hepatitis B? Hepatitis B is the world’s most common liver infection. It is caused by the hepatitis B virus (HBV), which can attack and injure the liver.
MARYLAND PREFERRED DRUG LIST - Provider Synergies
www.providersynergies.comcc-Clinical criteria can be found at the link here ql- Quantity limits can be found at the link here All lowercase letters = generic product.
HIGH TECH LIST FEBRUARY 2017. DMA DMA NAME NON …
www.hse.iestrength: unit of meas. pack size pack size name qty code coding instruction price price date eff.